- Tytuł:
- Phase 1 Clinical Results for NP10679, a pH‐sensitive GluN2B‐selective N‐methyl‐d‐aspartate Receptor Inhibitor.
- Autorzy:
- Temat:
-
METHYL aspartate receptors
CEREBRAL ischemia
SUBARACHNOID hemorrhage
ISCHEMIC stroke
GABA receptors
BRAIN injuries
SUMATRIPTAN - Źródło:
- Clinical Pharmacology in Drug Development; Jul2023, Vol. 12 Issue 7, p706-717, 12p
Czasopismo naukowe